Deutsche Tageszeitung - Global Fund secures deal to slash HIV treatment price

Global Fund secures deal to slash HIV treatment price


Global Fund secures deal to slash HIV treatment price
Global Fund secures deal to slash HIV treatment price / Photo: © AFP/File

The Global Fund announced Wednesday a deal with generic pharmaceutical manufacturers to significantly slash the price of a cutting-edge HIV drug, in a move it said would save lives.

Change text size:

The Global Fund, a partnership set up in 2002 to battle AIDS, tuberculosis and malaria, said the agreement would make it possible to provide the advanced pill known as TLD for under $45 per person per year.

"This improved pricing -– a 25-percent reduction -– will allow governments in resource-limited settings to expand access to critical HIV services," it said in a statement.

The three-in-one pill bands together the drugs tenofovir disoproxil fumarate, lamivudine and dolutegravir.

The World Health Organization has recommended it as the preferred first-line HIV treatment for adults and adolescents, since it rapidly suppresses the virus that causes AIDS, has fewer side effects and is easy to take, the statement pointed out.

"The countries most affected by HIV face enormous fiscal constraints, and there are still millions of people who are HIV-positive who don't have access to quality treatment," Global Fund chief Peter Sands said in the statement.

"Reduced pricing for TLD means governments and other implementers of Global Fund grants can expand treatment programmes and invest more in prevention, saving more lives and reducing new infections."

Wednesday's announcement comes after the Global Fund, along with UNAIDS, the Bill & Melinda Gates Foundation and other partners in 2017 secured licensing agreements ensuring that TLD could be made available in low- and middle-income countries for up to $75 per person per year -- at the time an unprecedented pricing level.

Thanks to that deal, around 19 million more people living with HIV in resource-constrained settings are today receiving TLD, according to the Clinton Health Access Initiative.

(L.Svenson--DTZ)

Featured

Emergency Doctors Warn Hospitals Cannot Guarantee Patient Safety This Winter

The Irish Association for Emergency Medicine (IAEM) has issued a stark warning that many hospitals are nearing breaking point and cannot guarantee patient safety as the winter season begins. The association criticized the normalization of treating patients in corridors, stating it must never be accepted as a cost of balancing budgets, while the Irish Nurses and Midwives Organisation highlighted critical staffing shortages.

Outdated Marriage Beliefs Hide Sexual Abuse Among Older South Africans

Deeply rooted cultural beliefs that marriage grants automatic sexual rights are leaving many older South Africans unable to recognize sexual abuse within their relationships. Recent workshops in Gauteng have highlighted how these outdated norms, combined with shame and financial dependence, prevent victims from seeking help or understanding consent.

RCSI President Calls for Enhanced Surgical Research Support at Millin Meeting

Professor Michael Kerin, president of the Royal College of Surgeons in Ireland (RCSI), has called for increased support for surgeons to strengthen the nation's surgical research capacity. His remarks preceded the annual Millin Meeting, a gathering of leading healthcare experts focused on integrating innovation and clinical trials into everyday surgical practice.

Toddler Diagnosed With Leukemia After Symptoms Dismissed as Winter Illness

Manraj Singh Hans, now seven, was diagnosed with acute lymphoblastic leukemia in February 2023 after a prolonged period during which his early symptoms were repeatedly misdiagnosed as common infections. His parents, Narinder Singh and Parm Hans, initially dismissed signs of illness as winter fatigue before blood in the child’s diaper prompted urgent medical intervention.

Change text size: